144 ·Filed Sep 2, 2026

PVLA

PALVELLA THERAPEUTICS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed29d 22h ago SEC0001950047-26-008991
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine advance notice of a small insider sale. Monitor for the actual Form 4 filing to confirm execution, but the amount is too small to warrant a trading response. No material read-through for the stock.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
PVLA ▼ -14.79% at T+20d
NEUTRAL call ✗ call lost -14.79% · α vs SPY -13.61% · entry $155.47 → $132.47
Next anchor: T+60d in 8w
Entry anchored
Sep 2, 04:00 PM ET
via 1-min bar
T+1d
+1.14%
call +1.14% · α +1.52%
$157.24
settled 29d ago
T+5d
-3.43%
call -3.43% · α -2.29%
$150.13
settled 22d ago
T+20d
-14.79%
call -14.79% · α -13.61%
$132.47
settled yesterday
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

Director Christopher Kiritsy filed a Form 144 notice of intent to sell 375 shares of Palvella Therapeutics, valued at approximately $58,875, from a stock option exercise. The proposed sale is immaterial relative to the company's $2.2B market cap and represents a routine insider transaction with no meaningful signal.

Key Facts

  • Insider: Director Christopher P. Kiritsy
  • Proposed sale: 375 shares, estimated value $58,875
  • Shares acquired via stock option exercise on the same date
  • Sale planned for 09/02/2026 on NASDAQ
  • Amount represents ~0.0027% of $2.2B market cap

Financial Impact

Proceeds of ~$58,875 from a director's sale; negligible relative to market cap.

Risk Factors

  • None material — the proposed sale is trivial in size and from a director, not top management.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-008991
Document: 0001950047-26-008991-index.html0001950047-26-008991
Document: 0001950047-26-008991.txt0001950047-26-008991
24 reports for PVLA
Performance horizon
67% Hit rate 4 of 6 directional calls best @ T+60▲ +35.07%May 15, 2026
Filters
Rows
Reports for PVLA — sortable, filterable
TypeNow
Sep 2, 2026
4w ago
144
NEUTRAL ★ 2/10
$155.47 $132.47▼ −14.79%▼ −13.61%$132.47 (−14.79%)
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 6/10
$152.22 $157.00▲ +3.14%▲ +4.05%$132.47 (−12.97%)
Aug 4, 2026
8w ago
8-K
NEUTRAL ★ 5/10
$151.99 $150.55▼ −0.95%▲ +0.29%$132.47 (−12.84%)
Jul 30, 2026
9w ago
Press Release
NEUTRAL ★ 2/10
$150.19 $150.33▲ +0.09%▼ −3.87%$132.47 (−11.80%)
Jul 28, 2026
9w ago
Press Release
NEUTRAL ★ 2/10
$142.84 $148.24▲ +3.78%▲ +0.40%$132.47 (−7.26%)
Jun 30, 2026
13w ago
8-K
NEUTRAL ★ 2/10
$152.82 $141.77▼ −7.23%▼ −6.20%$132.47 (−13.32%)
Jun 22, 2026
14w ago
Press Release
BULLISH ★ 7/10
$118.84 $157.24▲ +32.31%▲ +32.46%$132.47 (+11.47%)
Jun 16, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$110.12 $149.68▲ +35.92%▲ +35.72%$132.47 (+20.30%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 3/10
$106.38 $151.04▲ +41.98%▲ +40.09%$132.47 (+24.53%)
May 15, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$114.24 $116.51▲ +1.99%▼ −0.13%$132.47 (+15.96%)
Showing 10 of 24

US Market Status

Market Closed — Opens Mon (63h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access